Updated
Updated · USA TODAY · Jun 13
GHK-Cu Peptide Draws Anti-Aging Buzz as 1973 Discovery Faces Thin Human Evidence
Updated
Updated · USA TODAY · Jun 13

GHK-Cu Peptide Draws Anti-Aging Buzz as 1973 Discovery Faces Thin Human Evidence

3 articles · Updated · USA TODAY · Jun 13

Summary

  • GHK-Cu — a copper peptide first identified in 1973 — is drawing fresh attention in skincare and longevity circles for claims it may support regeneration and reduce visible aging.
  • Topical use drives much of that interest: early studies suggest it may boost collagen and elastin, aid wound healing and possibly support hair growth with less irritation than retinoids.
  • Human evidence remains limited, especially beyond creams and serums, with broader claims around brain protection, nerve repair and lung healing still based largely on lab and animal research.
  • Safety questions center on oral and injectable products sold by wellness clinics and online, where FDA approval for anti-aging use is lacking and dosing, purity and long-term effects remain unclear.
  • Experts say topical GHK-Cu appears generally safe, but people who are pregnant, take medications or have copper-metabolism disorders such as Wilson’s disease should seek medical advice first.

Insights

Is the trendy GHK-Cu peptide a breakthrough anti-aging secret or a risky, unregulated wellness gamble?
Could your vitamin C serum be making your popular GHK-Cu anti-aging product completely useless?